Acromegaly and Cushing’s Drugs Sold to Italian Pharma Company
An article in fiercepharma.com discusses the sale by Novartis of the drugs Signifor, Signifor LAR and osilodrostat to an Italian drugmaker called Recordati for $390 million upfront. It is unclear how or if this will affect patients in terms of price or availability. Read more:
https://www.fiercepharma.com/pharma/novartis-offloads-lagging-endocrine-drugs-pipeline-followup-to-recordati-for-390m
